<DOC>
	<DOCNO>NCT02147691</DOCNO>
	<brief_summary>The pilot study investigate whether combination treatment Finacea 15 % Gel Brimonidine 0.33 % Gel could effective Brimonidine 0.33 % Gel monotherapy treat papules/pustules erythema associate rosacea .</brief_summary>
	<brief_title>Finacea 15 % Brimonidine 0.33 % Gel Treatment Rosacea - A Pilot Study</brief_title>
	<detailed_description>Acne rosacea chronic inflammatory disease different component include inflammatory lesion ( papules/pustules ) , erythema telangiectasia . Brimonidine 0.33 % Gel primarily affect erythematous component rosacea . As , combination treatment standard rosacea treatment , Finacea 15 % Gel , may provide additional relief inflammatory component rosacea .</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Male Female 18 year age old Female subject childbearing potential must negative urine pregnancy test Baseline Female subject childbearing potential must practice reliable method contraception throughout study Moderate severe rosacea Investigator Global Assessment ( IGA ) score 3 4 Able understand comply requirement study sign Informed Consent/Health Insurance Portability Accountability Authorization form Female subject pregnant , breast feeding childbearing potential practicing reliable method birthcontrol History hypersensitivity idiosyncratic reaction component test medication Subjects complete proper washout period prohibit medication and/or procedures Medical condition contraindicates subject 's participation study Alcohol drug abuse evident within past 5 year History poor cooperation , noncompliance medical treatment , unreliability Participation investigational drug study within 30 day Baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>